HBK Sorce Advisory’s Neuronetics STIM Stock Holding History

HBK Sorce Advisory’s Portfolio STIM Stock Details STIM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-38,680	Closed	-$142K	–	629
2025 Q1	$142K	Buy	+38,680	New	+$141K	﹤0.01%	552

Other funds holding STIM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

MCM

Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return

MHP

Manatuck Hill Partners Westport, Connecticut $370M AUM 95.53% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wexford Capital West Palm Beach, Florida $690M AUM 57.92% 1-Year Est. Return

HBK Sorce Advisory's STIM Position: Q2 2025 in Review

HBK Sorce Advisory sold out of Neuronetics (STIM) in Q2 2025, closing a stake of 38,680 shares — an estimated $142K sold.

HBK Sorce Advisory first reported a position in STIM in Q1 2025 and held it in 1 quarter. The position peaked at $142K in Q1 2025. 90 funds tracked by Wall St. Rank hold STIM as of Q2 2025.

HBK Sorce Advisory reported no remaining Neuronetics position as of Q2 2025 after selling out during the quarter.
HBK Sorce Advisory sold 38,680 Neuronetics shares in Q2 2025, an estimated $142K.
HBK Sorce Advisory first reported a position in Neuronetics in Q1 2025 and held it in 1 quarter.
HBK Sorce Advisory's Neuronetics position peaked at $142K in Q1 2025.
90 funds tracked by Wall St. Rank held Neuronetics as of Q2 2025.

Based on HBK Sorce Advisory's 13F filing for Q2 2025, filed 4 Aug 2025.